Michael A. Metzger, President and COO at Syndax Pharmaceuticals Inc (SNDX), sold 48,874 shares at $19.51 ($954K) on 2021-09-27, disclosed to the SEC on 2021-09-28.
Open-market sale of $954k SNDX by President and COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.51 | 24,437 | $477K | 50.0% |
| 2 | $19.51 | 24,437 | $477K | 50.0% |
| Total | $19.51 avg | 48,874 | $954K | 100% |
| Filing → |
| SNDX | SELL | 2026-02-10 | $361K | — | Filing → |
| SNDX | SELL | 2026-02-06 | $153K | — | Filing → |
| SNDX | SELL | 2025-09-08 | $5.2M | — | Filing → |